Question · Q4 2025
Edlain Rodriguez asked about the competitive pricing pressure observed in Brazil and parts of Asia, inquiring if similar dynamics could occur in North America or Europe and how well these markets are protected from generics.
Answer
CEO Chuck Magro explained that markets are fundamentally different structurally, and while generics are present everywhere, the unique situation in Brazil is due to import policies and ample supply. He noted potential constructive changes from China's export controls (repealed export VAT, M&A among generics) and expects slow global growth in 2026, with Brazil facing pricing headwinds but other markets remaining healthy.
Ask follow-up questions
Fintool can predict
CTVA's earnings beat/miss a week before the call